Global disparities in regulatory approval of prophylactic vaccines, 2005–2024
Journal of Global Health · 10.07.2026 · 16
DOI: 10.7189/jogh.16.04145 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Global Health, online erschienen am 10.07.2026. Verfasst von Rizhen Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Global Health, School of Public Health, Peking University, Beijing, China. Hauptthemen laut MEDLINE: Vaccines, Drug Approval, Global Health. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Global Health, School of Public Health, Peking University, Beijing, China.
- Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China.
- International Research Centre for Medicinal Administration, Peking University, Beijing, China.
- Institute for Global Health and Development, Peking University, Beijing, China.
Zitieren
APA
Wang, R., Chen, J., Huang, Y., & Xu, M. (2026). Global disparities in regulatory approval of prophylactic vaccines, 2005–2024. Journal of Global Health, 16. https://doi.org/10.7189/jogh.16.04145
Vancouver
Wang R, Chen J, Huang Y, Xu M. Global disparities in regulatory approval of prophylactic vaccines, 2005–2024. Journal of Global Health. 2026;16. doi:10.7189/jogh.16.04145
BibTeX
@article{Wang2026,
author = {Wang, Rizhen and Chen, Jing and Huang, Yangmu and Xu, Ming},
title = {Global disparities in regulatory approval of prophylactic vaccines, 2005–2024},
journal = {Journal of Global Health},
year = {2026},
volume = {16},
doi = {10.7189/jogh.16.04145}
}
EUVIMED